Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-07-18
2006-07-18
Solola, Taofiq (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S247000, C514S374000, C514S473000, C514S563000, C544S392000, C544S393000, C548S236000, C548S577000, C549S295000, C562S439000
Reexamination Certificate
active
07078404
ABSTRACT:
The invention relates to acyl-3-carboxyphenylurea derivatives and to their physiologically tolerated salts and physiologically functional derivatives.The invention relates to compounds of formula I,in which the radicals have the given meanings, and to their physiologically tolerated salts and processes for preparing them. The compounds are, for example, suitable for use as antidiabetics.
REFERENCES:
patent: 5190923 (1993-03-01), Vincent et al.
patent: 6221633 (2001-04-01), Ertl
patent: 6221897 (2001-04-01), Baringhaus
patent: 6245744 (2001-06-01), Baringhaus
patent: 6342512 (2002-01-01), Kirsch
patent: 6380230 (2002-04-01), Brodin et al.
patent: 6506778 (2003-01-01), Defossa et al.
patent: 2003/0144332 (2003-07-01), Glombik
patent: 2004/0077716 (2004-04-01), Defossa et al.
patent: 2004/0087659 (2004-05-01), Defossa et al.
patent: 10142734 (2003-03-01), None
patent: 0 193 249 (1986-09-01), None
patent: 0 462 884 (1993-06-01), None
patent: WO 97/26265 (1997-07-01), None
patent: WO 97/41097 (1997-11-01), None
patent: WO 96/08871 (1998-03-01), None
patent: WO 99/03861 (1999-01-01), None
patent: WO 99/15525 (1999-04-01), None
patent: WO 00/40569 (2000-07-01), None
patent: WO 00/83208 (2000-10-01), None
patent: WO00/64876 (2000-11-01), None
patent: WO00/64888 (2000-11-01), None
patent: WO 00/66585 (2000-11-01), None
patent: WO 00/71549 (2000-11-01), None
patent: WO 00/78312 (2000-12-01), None
patent: WO 01/09111 (2001-02-01), None
patent: WO 01/83451 (2001-11-01), None
patent: WO 01/85695 (2001-11-01), None
patent: WO 01/91752 (2001-12-01), None
patent: WO 01/94300 (2001-12-01), None
Asakawa A et al., Cocaine-Amphetamine-Regulated Transcript Influences Energy Metabolism, Anxiety and Gastric Emptying in Mice, Hormone and Metabolic Research, 2001, vol. 33(9), pp 554-558.
Drueckes P et al., Photometric Microliter Assay of Inorganic Phosphate in the Presence of Acid-Labile Organic Phosphates, Anal. Biochem, 1995, vol. 230(1), pp. 173-177.
Engers H D et al., Kinetic mechanism of phosphorylase a. I. Initial velocity studies, Can J. Biochem., 1970, vol. 48(7) pp 746-854.
Lee Daniel W et al., Leptin agonists as a potential approach to the treatment of obesity, Drugs of the Future, 2001, vol. 26(9), pp. 873-881.
Okada Hiroshi et al., Syntheisis and Antiutumer Activities of Prodrugs of Benzopylphenylureas, Chem. Pharm. Bull., 1994, vol. 42(1), pp. 57-61.
Salvador Javier et al. Perspectives in the terapeutic use of leptin, Expert Opinion on Pharmacotherapy. 201, vol. 2(10, pp 1615-1622, (2001).
Tyle Praveen, Iontophoretic Devices for Drug Delivery, Pharmaceutical Research, 1986, vol. 3, No. 6, pp. 318-326.
Zunft H J et al., Carob Pulp Preparation for Treatment of Hypercholesterolemia, Advances in therapy, 2001, vol. 18(5), pp. 230-236.
Burger Hans-Joerg
Defossa Elisabeth
Enhsen Alfons
Herling Andreas
Kadereit Dieter
Kurys Barbara E.
Sackey Ebenezer
Sanofi-Aventis Deutschland GmbH
Solola Taofiq
LandOfFree
Acyl-3-carboxyphenylurea derivatives, processes for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acyl-3-carboxyphenylurea derivatives, processes for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acyl-3-carboxyphenylurea derivatives, processes for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3554751